Additionally, the results of immunohistochemistry for IL‐1β and TNF‐α (Figure S8) suggest that EA may alleviate AD pathology by suppressing astrocyte or microglia‐related inflammation. The gene discussed is TNF; the disease is Alzheimer disease.